2025 ICD-10-PCS Procedure Code XW03388
Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History
Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History
Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History
Introduction of Tabelecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History
Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History
Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2 Code History
Introduction of Afamitresgene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History
Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History
Introduction of Lefamulin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Code History
Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10 Code History
Introduction of Mosunetuzumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History